ABAC Therapeutics Announces €16 Million Series A to develop therapeutic solutions to fight antibiotic-resistant bacteria

by Abac Therapeutics

ABAC Therapeutics (ABAC), a leader in pathogen-specific antibiotics, announced today the closing of a €16 million Series A round. The financing was led by Pontifax with participation from the Global...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Estrategias de Negociación con Inversor...

by Foro Capital Pymes

La negociación con inversores es un paso crucial y a menudo intimidan...

Photos Stream